美国老年人群中按种族、族裔和地理区域划分完成新冠疫苗基础免疫系列时间的差异
该观察性研究利用COVVAXAGE数据库纳入2021年1月1日至12月31日接种新冠疫苗基础系列(两剂)的Medicare受益人,评估接种两剂间时间的种族差异并按城乡分类分析。共纳入11,924,990名受益人,大多数(97.1%)按时接种第二剂;黑人和农村受益人延迟接种第二剂的风险分别高于白人和城市受益人(RR=1.30和1.27),且种族差异程度随城乡分类而变化。
要点
- 97.1%的Medicare受益人按时接种第二剂新冠疫苗。
- 黑人受益人延迟接种第二剂的风险是白人的1.30倍(RR=1.30,95%CI 1.28-1.31)。
- 农村受益人延迟接种第二剂的风险是城市受益人的1.27倍(RR=1.27,95%CI 1.25-1.29)。
核心结论
- 大多数受益人按时接种了第二剂新冠疫苗,但观察到种族差异且差异程度随地理区域而变化。
研究设计与样本
- 观察性研究,使用COVVAXAGE数据库,纳入2021年1月1日至2021年12月31日期间接种新冠疫苗基础系列(两剂)的Medicare受益人。
- 共纳入11,924,990名受益人,平均年龄75.4岁,60%为女性,80%为白人。
- 使用g-formula方法按城乡分类评估接种两剂间时间的种族差异。
主要发现
- 97.1%的受益人按时接种了第二剂疫苗。
- 黑人受益人延迟接种第二剂的相对风险为RR=1.30(95%CI 1.28-1.31),高于白人受益人。
- 农村受益人延迟接种第二剂的相对风险为RR=1.27(95%CI 1.25-1.29),高于城市受益人。
- 延迟接种的种族差异程度随城乡分类程度而变化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Racial and ethnic disparities in COVID-19 vaccine access are well-documented; however, few studies have examined whether racial disparities are modified by other factors, including geographic location and area-level deprivation. METHODS: We conducted an observational study using the COVVAXAGE database. Medicare beneficiaries who received the COVID-19 vaccine primary series (two doses) between 01/01/2021 and 12/31/2021 were included. Racial differences in the time between doses was assessed by urbanicity using g-formula methods. RESULTS: We identified 11,924,990 beneficiaries (mean age = 75.4; 60 % female; 80 % White). Most beneficiaries (97.1 %) received their second vaccine on time. Delayed second doses were more common among beneficiaries who were Black (RRdelayed = 1.30, 95 %CI = 1.28-1.31) and rural (RRdelayed = 1.27, 95 %CI = 1.25-1.29) relative to White and urban beneficiaries. Racial disparities in delayed vaccinations varied in magnitude by degree of urbanicity. CONCLUSIONS: Most beneficiaries received their second COVID-19 vaccine on time. Racial disparities were observed and shown to vary by geographic area.
引用
- Deng Y, Hayes KN, Zhao Y, et al. Variation in the time to complete the primary COVID-19 vaccine series by race, ethnicity, and geography among older US adults. Vaccine. 2024. PMID: 39515194. doi:10.1016/j.vaccine.2024.126501
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。